Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes

NCT02700334 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Prediabetes
Impaired Fasting Glucose
Impaired Glucose Tolerance

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

University of Guadalajara